Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine
· Delayed Price · Currency is JOD · Price in USD 3.850
0.00 (0.00%)
At close: Jun 17, 2025
Jerusalem Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 6.87 | 5.04 | 6.96 | 7.17 | 6.6 | 3.73 | Upgrade
|
| Depreciation & Amortization | 1.59 | 1.6 | 1.56 | 2.22 | 2.44 | 2.34 | Upgrade
|
| Other Amortization | 0.52 | 0.57 | 0.55 | 0.6 | 0.6 | 0.57 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | -0 | -0.11 | - | -0.01 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.35 | -0.79 | 0.15 | -0 | 0.01 | -0 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 0 | -0.02 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.85 | 1.83 | 0.14 | 0.63 | 0.43 | 0.22 | Upgrade
|
| Other Operating Activities | 2.37 | 2.48 | -0.23 | 1.97 | 1.91 | 0.13 | Upgrade
|
| Change in Accounts Receivable | -3.7 | -3.89 | 1.48 | -0.76 | -7.17 | -4.75 | Upgrade
|
| Change in Inventory | 2.49 | 1.67 | 1.3 | 3.76 | -1.01 | 0.14 | Upgrade
|
| Change in Accounts Payable | -0.17 | -0.24 | -2.95 | 1.12 | 0.78 | -0.51 | Upgrade
|
| Change in Other Net Operating Assets | 5.33 | 3.49 | 0.35 | 0.29 | 1.48 | 0.06 | Upgrade
|
| Operating Cash Flow | 15.8 | 11.75 | 9.2 | 17 | 6.05 | 1.91 | Upgrade
|
| Operating Cash Flow Growth | 181.19% | 27.79% | -45.90% | 181.03% | 217.13% | -19.70% | Upgrade
|
| Capital Expenditures | -2.47 | -1.81 | -1.36 | -0.68 | -2.19 | -1.46 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | 0.91 | - | 0.02 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.97 | -0.82 | -0.59 | -0.49 | -0.11 | -0.49 | Upgrade
|
| Investment in Securities | -1.31 | -0.52 | -3.73 | -2.58 | 0.59 | - | Upgrade
|
| Other Investing Activities | 0.54 | 0.29 | -0.08 | - | - | - | Upgrade
|
| Investing Cash Flow | -4.22 | -2.87 | -7.15 | -3.75 | -1.69 | -1.95 | Upgrade
|
| Long-Term Debt Issued | - | 1.86 | 1.57 | 0.14 | - | 0.78 | Upgrade
|
| Long-Term Debt Repaid | - | -2.76 | -1.5 | -0.62 | -1.9 | -1.32 | Upgrade
|
| Net Debt Issued (Repaid) | -1.91 | -0.9 | 0.07 | -0.48 | -1.9 | -0.54 | Upgrade
|
| Common Dividends Paid | -1.68 | -1.69 | -2.55 | -2.14 | -1.34 | -1.65 | Upgrade
|
| Other Financing Activities | -0.33 | -0.36 | -0.23 | -0.2 | -0.16 | -0.74 | Upgrade
|
| Financing Cash Flow | -3.92 | -2.95 | -2.7 | -2.82 | -3.4 | -2.93 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.31 | -0.78 | -0.49 | -8.14 | 2.51 | 3.79 | Upgrade
|
| Net Cash Flow | 7.98 | 5.16 | -1.14 | 2.29 | 3.48 | 0.81 | Upgrade
|
| Free Cash Flow | 13.33 | 9.94 | 7.84 | 16.32 | 3.86 | 0.45 | Upgrade
|
| Free Cash Flow Growth | 244.03% | 26.79% | -51.95% | 322.88% | 764.17% | -44.73% | Upgrade
|
| Free Cash Flow Margin | 31.81% | 24.96% | 19.77% | 35.37% | 8.35% | 1.23% | Upgrade
|
| Free Cash Flow Per Share | 0.74 | 0.55 | 0.44 | 0.91 | 0.21 | 0.03 | Upgrade
|
| Cash Income Tax Paid | 0.2 | 0.15 | 2.01 | 0.65 | 0.02 | 0.07 | Upgrade
|
| Levered Free Cash Flow | 11.28 | 8.43 | 5.08 | 12.57 | 2.48 | -1.18 | Upgrade
|
| Unlevered Free Cash Flow | 11.28 | 8.44 | 5.11 | 12.61 | 2.51 | -1.15 | Upgrade
|
| Change in Net Working Capital | -7.56 | -4.71 | 0.67 | -5.46 | 3.21 | 4.62 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.